Goodbye warts, hello vitiligo: Candida antigen-induced depigmentation

Area of Science:

• Dermatology
• Immunology

Background:

• Topical immune modulators can rarely cause skin depigmentation.
• Vitiligo is an autoimmune condition resulting in loss of skin color.

Observation:

• A case study documenting a patient who developed vitiligo.
• The vitiligo appeared at the site of a Candida antigen injection.

Findings:

• This is the first reported instance of vitiligo occurring post-Candida antigen injection.
• The event suggests a potential link between Candida antigen immunotherapy and localized vitiligo.

Implications:

• Highlights a rare adverse effect of Candida antigen immunotherapy.
• Suggests further investigation into the immunologic mechanisms linking Candida antigens to vitiligo development.